Literature DB >> 25060491

Compulsive-like responding for opioid analgesics in rats with extended access.

Carrie L Wade1, Leandro F Vendruscolo1, Joel E Schlosburg1, Daniel O Hernandez1, George F Koob1.   

Abstract

The abuse of prescription opioids that are used for the treatment of chronic pain is a major public health concern, costing ∼$53.4 billion annually in lost wages, health-care costs, and criminal costs. Although opioids remain a first-line therapy for the treatment of severe chronic pain, practitioners remain cautious because of the potential for abuse and addiction. Opioids such as heroin are considered very rewarding and reinforcing, but direct and systematic comparisons of compulsive intake between commonly prescribed opioids and heroin in animal models have not yet been performed. In the present study, we evaluated the potential for compulsive-like drug seeking and taking, using intravenous self-administration of oxycodone, fentanyl, and buprenorphine in rats allowed long access sessions (12 h). We measured compulsive-like intake using an established escalation model and responding on a progressive ratio schedule of reinforcement. We compared the potential for compulsive-like self-administration of these prescription opioids and heroin, which has been previously established to induce increasing intake that models the transition to addiction in humans. We found that animals that self-administered oxycodone, fentanyl, or heroin, but not buprenorphine had similar profiles of escalation and increases in breakpoints. The use of extended access models of prescription opioid intake will help better understand the biological factors that underlie opioid dependence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25060491      PMCID: PMC4443956          DOI: 10.1038/npp.2014.188

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  34 in total

1.  Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.

Authors:  P Huang; G B Kehner; A Cowan; L Y Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

2.  Persistent increase in the motivation to take heroin in rats with a history of drug escalation.

Authors:  S H Ahmed; J R Walker; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

3.  Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction.

Authors:  P V Piazza; V Deroche-Gamonent; F Rouge-Pont; M Le Moal
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

4.  Neurobiological evidence for hedonic allostasis associated with escalating cocaine use.

Authors:  Serge H Ahmed; Paul J Kenny; George F Koob; Athina Markou
Journal:  Nat Neurosci       Date:  2002-07       Impact factor: 24.884

Review 5.  Discriminative stimulus properties of narcotic analgesic drugs.

Authors:  F C Colpaert
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

6.  Place aversion induced by blockade of mu or activation of kappa opioid receptors in the dorsal periaqueductal gray matter.

Authors:  A B Sante; M J Nobre; M L Brandão
Journal:  Behav Pharmacol       Date:  2000-11       Impact factor: 2.293

7.  Relative reinforcing effects of three opioids with different durations of action.

Authors:  M C Ko; J Terner; S Hursh; J H Woods; G Winger
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

8.  Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.

Authors:  Elyssa B Margolis; Gregory O Hjelmstad; Antonello Bonci; Howard L Fields
Journal:  J Neurosci       Date:  2003-11-05       Impact factor: 6.167

Review 9.  Neurobiological mechanisms in the transition from drug use to drug dependence.

Authors:  George F Koob; Serge H Ahmed; Benjamin Boutrel; Scott A Chen; Paul J Kenny; Athina Markou; Laura E O'Dell; Loren H Parsons; Pietro Paolo Sanna
Journal:  Neurosci Biobehav Rev       Date:  2004-01       Impact factor: 8.989

10.  Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

Authors:  Patrick M Beardsley; Mario D Aceto; Charles D Cook; Edward R Bowman; Jennifer L Newman; Louis S Harris
Journal:  Exp Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.157

View more
  61 in total

1.  Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.

Authors:  Rachel M Enga; Asti Jackson; M Imad Damaj; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

Review 2.  Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.

Authors:  Eugene A Kiyatkin
Journal:  Neuropharmacology       Date:  2019-02-05       Impact factor: 5.250

Review 3.  Modeling the development of drug addiction in male and female animals.

Authors:  Wendy J Lynch
Journal:  Pharmacol Biochem Behav       Date:  2017-06-15       Impact factor: 3.533

4.  Fentanyl-Induced Brain Hypoxia Triggers Brain Hyperglycemia and Biphasic Changes in Brain Temperature.

Authors:  Ernesto Solis; Keaton T Cameron-Burr; Yavin Shaham; Eugene A Kiyatkin
Journal:  Neuropsychopharmacology       Date:  2017-08-29       Impact factor: 7.853

5.  Chronic voluntary caffeine intake in male Wistar rats reveals individual differences in addiction-like behavior.

Authors:  Christine H Lee; Olivier George; Adam Kimbrough
Journal:  Pharmacol Biochem Behav       Date:  2020-02-24       Impact factor: 3.533

6.  Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2019-12-04       Impact factor: 5.250

Review 7.  Utility of Nonhuman Primates in Substance Use Disorders Research.

Authors:  Matthew L Banks; Paul W Czoty; Sidney S Negus
Journal:  ILAR J       Date:  2017-12-01

8.  Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats.

Authors:  Laura L Erwin; Mark R Nilges; Zachary B Bondy; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

9.  Repeated blast model of mild traumatic brain injury alters oxycodone self-administration and drug seeking.

Authors:  Natalie N Nawarawong; Megan Slaker; Matt Muelbl; Alok S Shah; Rachel Chiariello; Lindsay D Nelson; Matthew D Budde; Brian D Stemper; Christopher M Olsen
Journal:  Eur J Neurosci       Date:  2018-12-14       Impact factor: 3.386

10.  Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats.

Authors:  Jacques D Nguyen; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.